Compare Pfizer Inc (PFE) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Zillow Group Inc Class C — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Zillow Group Inc Class C trades at $31.73 (market cap $7.28B). The key difference: Pfizer Inc is far larger — about 19.5× Zillow Group Inc Class C's market cap, and Pfizer Inc pays a 6.9% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals.
| PFE | Z | |
|---|---|---|
Market Cap | $142.14B | $7.28B |
Volume | 29,869,932 | — |
Sector | Health | Media |
52-Week High | $28.56 | $90.35 |
52-Week Low | $23.29 | $29.41 |
Enterprise Value | $192.80B | $6.93B |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
Zillow Group (Z) trades at $33.03, down 2.58% amid legal headwinds, with technicals neutral and fundamentals showing improving profitability. Revenue grew to $2.58B in 2025 with net income turning positive at $23M, though valuation multiples remain elevated with a P/E of 132.04. The stock faces significant legal overhang from multiple class-action lawsuits alleging securities fraud related to an anticompetitive agreement.
The outlook is cautious; while earnings beat expectations in two recent quarters and analyst consensus targets $57.67, near-term risks from litigation and a high P/E ratio temper upside potential. Investment appeal hinges on legal resolution and sustained margin expansion beyond current modest levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
